Financials

  • Market Capitalization 260.75 M
  • Employee 78
  • Founded 2018
  • CEO N/A
  • Website www.centurytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00PM8N5W0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.11
Relación precio/flujo de caja
0.79

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3358
BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock
3.26 USD-1.51%-9.44%-33.60%-71.53%261.37 M USD
3361
GLSI
Greenwich LifeSciences, Inc. - Common stock
17.77 USD+7.50%+4.65%+17.29%+74.22%260.83 M USD
3370
IKT
Inhibikase Therapeutics, Inc. - Common Stock
1.85 USD-6.09%-7.50%-20.94%+17.09%258.14 M USD
3371
SABS
SAB Biotherapeutics, Inc. - Common Stock
2.83 USD-5.03%-9.29%-17.25%+23.58%257.49 M USD

Noticias